About Solis Pharmaceuticals
Solis Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2021, and was acquired by PI Health Sciences in June 2023. Manufacturer of drugs. The company has 42 employees. Its Indian entity Solis Pharmaceutical Industries Private Limited reported revenue of ₹13.51 Cr. Its focus areas include Traditional Pharmaceuticals.
Company details
Solis Pharmaceuticals, established in 2021, excels in providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- Employees 42
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website solispharma.in
- Acquired by PI Health Sciences (Jun 2023)
- Legal Name Solis Pharmaceutical Industries Private Limited
- Date of Incorporation 09 Sep, 2021
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹13.51 Cr
FY 2025 · +22% YoY
- Net Profit₹31.2 Lakh
FY 2025 · 2% margin
- EBITDA₹1.02 Cr
FY 2025 · 8% margin
- Investors
- Employee Count42
- Acquired byPI Health Sciences
(Jun 2023)
Associated legal entities of Solis Pharmaceuticals
Solis Pharmaceuticals operates through Solis Pharmaceutical Industries Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Solis Pharmaceutical Industries Private Limited CIN U24299TG2021PTC154809 | Active | 09 Sep 2021 | Hyderabad, Telangana | ₹13.5 Cr | 42 | 2 | View details |
Investors in Solis Pharmaceuticals
Solis Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include PI Health Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specializes in CRO and CDMO services for medicinal chemistry and API manufacturing. | 2021 | pihealthsciences.com | Udaipur, India |
Investor details for Solis Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Solis Pharmaceutical Industries Private Limited (Solis Pharmaceuticals)
Solis Pharmaceutical Industries Private Limited is the primary company behind Solis Pharmaceuticals. The board of Solis Pharmaceutical Industries Private Limited currently have 2 directors; the longest-serving is Vijay Kumar Vembakam, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vijay Kumar Vembakam DIN 07209805 | Director | 09 Sep 2021 | 5 yrs 1 mo | Solis Pharmaceutical Industries Private Limited |
| Sandhya Vembakkam DIN 07199192 | Director | 09 Sep 2021 | 5 yrs 1 mo | Solis Pharmaceutical Industries Private Limited |
People of Solis Pharmaceuticals
1 people are tracked at Solis Pharmaceuticals (1 in leadership); the tracked headcount is 42.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Solis Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Solis Pharmaceuticals
Figures of Solis Pharmaceutical Industries Private Limited, the primary company behind Solis Pharmaceuticals, for FY 2025. Revenue was ₹13.51 Cr (+22% year on year). Net profit was ₹31.2 Lakh (2% margin). EBITDA was ₹1.02 Cr (8% margin). Revenue has grown at a compounded annual rate of +22% over three years.
- ₹13.51 CrRevenue · FY 2025 · +22% YoY
- ₹31.2 LakhNet profit · 2% margin
- ₹1.02 CrEBITDA · 8% margin
- ₹2.45 CrPaid-up capital
- 42Employees (provident fund records)
- +22%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Solis Pharmaceutical Industries Private Limited are on its company page.
Detailed financial statements for Solis Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Solis Pharmaceuticals
2 dated milestones of Solis Pharmaceuticals across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Solis Pharmaceuticals is founded.
- Exit Acquired by PI Health Sciences.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Solis Pharmaceuticals (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Solis Pharmaceuticals
Complete news archive for Solis Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Solis Pharmaceuticals
Solis Pharmaceuticals was founded in 2021.
Solis Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Solis Pharmaceuticals has 42 employees.
The primary company behind Solis Pharmaceuticals, Solis Pharmaceutical Industries Private Limited, reported revenue of ₹13.51 Cr for FY 2025, up 22% year on year.
Solis Pharmaceuticals, established in 2021, excels in providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Solis Pharmaceuticals has 1 investor. Key investors include PI Health Sciences.
Solis Pharmaceuticals operates through Solis Pharmaceutical Industries Private Limited.
Yes. Solis Pharmaceuticals was acquired by PI Health Sciences in June 2023.
The legal entities of Solis Pharmaceuticals currently have 2 directors, including Vijay Kumar Vembakam, Sandhya Vembakkam.